3 months to expiry Ghana · FDA Ghana

TELFAST TABLET 120

Fexofanadine hydrochloride

FDA/SD.233-070717 TABLETS 120MG

What it does

Fexofenadine is an antihistamine used to relieve allergy symptoms.

Commonly used for: hay fever (allergic rhinitis), hives (urticaria)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.233-070717
Registration date
2023-07-10
Expiry date
2026-08-01
Status
3 months to expiry
Active ingredient
Fexofanadine hydrochloride
Dosage form
TABLETS
Strength
120MG
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Sanofi Winthrop
Country of origin
FRANCE
Manufacturer location
30 Av. Gustave Eiffel, 37100 Tours, France

Source: Food and Drugs Authority · fetched 2026-04-18 08:37:38 · updated 2026-07-31 04:00:07

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Fexofenadine is an antihistamine used to relieve allergy symptoms.

What it treats

  • hay fever (allergic rhinitis)
  • hives (urticaria)

How it works

It works by blocking the effects of histamine, a substance in the body that causes allergic symptoms.

Who it's for

This medication is suitable for adults and children who suffer from allergy symptoms.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: fexofanadine

Fexofenadine is a second-generation antihistamine primarily used to relieve symptoms associated with allergic rhinitis and chronic urticaria. It is a selective antagonist of peripheral H1 receptors, which helps to mitigate allergy symptoms without the sedative effects commonly associated with first-generation antihistamines.

Indications

  • Allergic rhinitis
  • Seasonal allergic rhinitis
  • Chronic idiopathic urticaria

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Fexofenadine works by selectively inhibiting the H1 histamine receptor, preventing histamine from binding to its receptor and thus reducing the effects of histamine such as vasodilation, increased vascular permeability, and sensory nerve stimulation. This mechanism leads to a decrease in allergy-related symptoms such as sneezing, itching, and runny nose.

Pharmacodynamics

Fexofenadine exhibits a rapid onset of action, typically within one hour of administration, and provides relief from allergy symptoms for up to 24 hours. It has minimal sedative effects due to its limited ability to cross the blood-brain barrier compared to first-generation antihistamines. The drug also has a long half-life, which supports once-daily dosing.

Pharmacokinetics

Fexofenadine is rapidly absorbed from the gastrointestinal tract, with peak plasma concentrations occurring about 2 to 3 hours post-dose. It undergoes minimal metabolism, primarily excreted unchanged in the urine and feces. The drug's bioavailability is affected by the presence of food, especially high-fat meals, which can reduce absorption.

Adverse effects

  • Headache
  • Drowsiness
  • Nausea
  • Dry mouth
  • Dizziness
  • Fatigue

Interactions

  • Antacids containing aluminum or magnesium may reduce the absorption and effectiveness of fexofenadine
  • Erythromycin and ketoconazole can increase fexofenadine levels

Precautions

  • Caution in patients with renal impairment
  • Use with caution in elderly patients

Pregnancy

Fexofenadine is classified as Category C, meaning that risks cannot be ruled out. Consult a healthcare professional before use.

Breast-feeding

It is not known whether fexofenadine is excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Tablets
  • Oral suspension
  • Extended-release tablets

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.